Poket News

Pfizer moves U.S. court against Aurobindo Pharma, Dr. Reddy’s on cancer drug

 

  • Pfizer Inc. and its group companies filed a petition in a U.S. court against Aurobindo Pharma Ltd and Dr Reddy’s Laboratories alleging that the Indian drug makers were planning separately to come out with generic versions of its blockbuster multi-billion dollar drug Ibrance (palbociclib) before expiration of its patent.
  • Pfizer filed the possible patent infringement petition against both the companies in the United States District Court for the District of Delaware on two counts last week.